Analysis of mechanisms of interaction between ciprofloxacin-based radiopharmaceutical labeled with technetium-99m and cultured Staphylococcus aureus
Related Experiment Video
Updated: Apr 21, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
S I Sazonova1, M R Karpova, Yu N Il'yushenkova
1Laboratory of Radionuclide Analysis, Research Institute of Cardiology, Siberian Division of the Russian Academy of Medical Sciences, Tomsk, Russia, sazonova_si@mail.ru.
Abstract:
Mechanisms of interaction between ciprofloxacin-based radiopharmaceutical labeled with technetium-99m and cultured Staphylococcus aureus were studied. The substance, reagent for radiopharmaceutical, and the radiopharmaceutical demonstrated similar bactericidal activity against the test bacterial cultures, which confirmed specific antibacterial activity of technetium-99m-labeled ciprofloxacin. The technetium-99m-labeled antibiotic reversibly interacts with inactivated Staphylococcus aureus culture, which indicates the existence of an additional non-specific pathway for radiopharmaceutical accumulation in the bacterial inflammation focus. Our experiment ruled out the possibility of binding free technetium-99m at concentrations <5% (its concentration in the radiopharmaceutical) with Staphylococcus aureus.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance

